Experience

CELL ALTERNATIV

• France
• Research Services
• 1 - 100 Employee

• Founder and CEO Cell Alternativ

  • Jul 2020 - Present

  Cellular alternative methods & In vitro tests Cellular alternative methods & In vitro tests



iTerra

• France
• Business Consulting and Services
• 1 - 100 Employee

• Project Lead Cell Alternativ

  • Jan 2020 - Present



THOR PERSONAL CARE

• Compiègne (60)

• In vitro toxicology manager

  • Jan 2008 - Nov 2019

  Design the in vitro strategy and scientific support for the development of new alternative methods. Monitoring of in vitro studies to assess the toxic potential of raw materials and finished formulations (Personal care and Chemical): skin irritation and corrosion, eye irritation, cytotoxicity and skin sensitization using cell models or reconstructed human tissues. Implementation of Good Laboratory Practices for accreditation COFRAC and AFSSAPS of the test facility. Management of human… Show more Design the in vitro strategy and scientific support for the development of new alternative methods. Monitoring of in vitro studies to assess the toxic potential of raw materials and finished formulations (Personal care and Chemical): skin irritation and corrosion, eye irritation, cytotoxicity and skin sensitization using cell models or reconstructed human tissues. Implementation of Good Laboratory Practices for accreditation COFRAC and AFSSAPS of the test facility. Management of human and material resources (engineers, technicians and students.) Seminars and technical training for customers. Show less Design the in vitro strategy and scientific support for the development of new alternative methods. Monitoring of in vitro studies to assess the toxic potential of raw materials and finished formulations (Personal care and Chemical): skin irritation and corrosion, eye irritation, cytotoxicity and skin sensitization using cell models or reconstructed human tissues. Implementation of Good Laboratory Practices for accreditation COFRAC and AFSSAPS of the test facility. Management of human… Show more Design the in vitro strategy and scientific support for the development of new alternative methods. Monitoring of in vitro studies to assess the toxic potential of raw materials and finished formulations (Personal care and Chemical): skin irritation and corrosion, eye irritation, cytotoxicity and skin sensitization using cell models or reconstructed human tissues. Implementation of Good Laboratory Practices for accreditation COFRAC and AFSSAPS of the test facility. Management of human and material resources (engineers, technicians and students.) Seminars and technical training for customers. Show less



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Technical manager in Cellular and Molecular Investigative Toxicology group

  • Oct 1998 - Dec 2007

  Implementation and validation of in vitro models (3D) to assess the potential toxicity of new molecules . Development of new in vitro technologies and improvement of the existing methods. Key person for laboratory organisation (planning, lab facilities and resources) Responsible for equipment qualification (CFR part 11, GLP compliance) Implementation and validation of in vitro models (3D) to assess the potential toxicity of new molecules . Development of new in vitro technologies and improvement of the existing methods. Key person for laboratory organisation (planning, lab facilities and resources) Responsible for equipment qualification (CFR part 11, GLP compliance)